Jason Haddock

Insider Reports History

Entity
Individual
Location
C/O Array Biopharma Inc., 3200 Walnut St, Boulder, CO
Signature
/s/ Peter Silverman as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jason Haddock:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Merus N.V. Director Share Option (right to buy) 17.7K $239K $13.52 May 7, 2024 Direct
Codiak BioSciences, Inc. Director Common Stock 8.75K Feb 16, 2023 Direct
Codiak BioSciences, Inc. Director Restricted Stock Units 0 Feb 16, 2023 Direct

Insider Reports Filed by Jason Haddock

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MRUS Merus N.V. May 7, 2024 1 $0 4 May 9, 2024 Director
MRUS Merus N.V. May 7, 2024 0 $0 3 May 9, 2024 Director
CDAKQ Codiak BioSciences, Inc. Feb 16, 2023 2 $0 4 Feb 21, 2023 Director
CDAKQ Codiak BioSciences, Inc. Jun 17, 2022 2 $0 4 Jun 21, 2022 Director
CDAKQ Codiak BioSciences, Inc. Feb 16, 2022 1 $0 4 Feb 18, 2022 Director
CDAKQ Codiak BioSciences, Inc. Jun 18, 2021 1 $0 4 Jun 22, 2021 Director